Targeted therapy to prevent progression of calcific aortic stenosis.
作者信息
Rajamannan Nalini M, Otto Catherine M
出版信息
Circulation. 2004 Sep 7;110(10):1180-2. doi: 10.1161/01.CIR.0000140722.85490.EA.
Abstract
摘要
相似文献
1
Targeted therapy to prevent progression of calcific aortic stenosis.
Circulation. 2004 Sep 7;110(10):1180-2. doi: 10.1161/01.CIR.0000140722.85490.EA.
2
Emerging medical treatments for aortic stenosis: statins, angiotensin converting enzyme inhibitors, or both?
Heart. 2006 Jun;92(6):729-34. doi: 10.1136/hrt.2005.066852.
3
[Treatment with statins and angiotensin-converting enzyme inhibitors in degenerative aortic stenosis--an up-date].
Rev Med Chir Soc Med Nat Iasi. 2009 Oct-Dec;113(4):964-74.
4
[Research progress on pharmacotherapy of calcific aortic valve disease].
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2016 May 25;45(4):432-438. doi: 10.3785/j.issn.1008-9292.2016.07.16.
5
Prevention of calcific aortic valve stenosis-fact or fiction?
Ann Med. 2009;41(2):100-8. doi: 10.1080/07853890802331394.
6
A medical therapy for aortic valve sclerosis and aortic valve stenosis? Rationale of the ASSIST study (Asymptomatic aortic Sclerosis/Stenosis: Influence of STatins): a large, observational, prospective, multicenter study of the Italian Society of Cardiovascular Echography.
J Cardiovasc Med (Hagerstown). 2006 Jul;7(7):464-9. doi: 10.2459/01.JCM.0000234763.76132.0d.
7
Targeting vasoactive peptides for managing calcific aortic valve disease.
Ann Med. 2017 Feb;49(1):63-74. doi: 10.1080/07853890.2016.1231933. Epub 2016 Nov 3.
8
(Pro)renin receptors and angiotensin converting enzyme 2/angiotensin-(1-7)/Mas receptor axis in human aortic valve stenosis.
Atherosclerosis. 2011 May;216(1):35-43. doi: 10.1016/j.atherosclerosis.2011.01.018. Epub 2011 Jan 21.
9
Role of statins in aortic valve disease.
Heart Fail Clin. 2006 Oct;2(4):395-413. doi: 10.1016/j.hfc.2006.09.011.
10
Statins for calcific aortic valve stenosis: into oblivion after SALTIRE and SEAS? An extensive review from bench to bedside.
Curr Probl Cardiol. 2010 Jun;35(6):284-306. doi: 10.1016/j.cpcardiol.2010.02.002.
引用本文的文献
1
Unraveling the Link Between Aortic Stenosis and Atherosclerosis: What Have We Learned?
Medicina (Kaunas). 2025 Jul 30;61(8):1375. doi: 10.3390/medicina61081375.
2
Calcific Aortic Stenosis-A Review on Acquired Mechanisms of the Disease and Treatments.
Front Cardiovasc Med. 2021 Sep 17;8:734175. doi: 10.3389/fcvm.2021.734175. eCollection 2021.
3
Early and Intermediate-Term Outcome of Balloon Aortic Valvuloplasty in Children With Aortic Stenosis and Left Ventricular Dysfunction at Tertiary Care Hospital.
Cureus. 2020 May 27;12(5):e8321. doi: 10.7759/cureus.8321.
4
MMP-12-Induced Pro-osteogenic Responses in Human Aortic Valve Interstitial Cells.
J Surg Res. 2019 Mar;235:44-51. doi: 10.1016/j.jss.2018.09.005. Epub 2018 Oct 23.
5
One problem two issues! Left ventricular systolic and diastolic dysfunction in aortic stenosis.
Ann Transl Med. 2014 Jan;2(1):10. doi: 10.3978/j.issn.2305-5839.2013.06.05.
6
Evaluation of the prevalence of coronary artery disease in patients with valvular heart disease.
J Cardiothorac Surg. 2014 Sep 2;9:153. doi: 10.1186/s13019-014-0153-1.
7
Degenerative valve disease and bioprostheses: risk assessment, predictive diagnosis, personalised treatments.
EPMA J. 2011 Mar;2(1):91-105. doi: 10.1007/s13167-011-0072-3. Epub 2011 Apr 3.
8
Care of patients with apparently asymptomatic severe aortic valve stenosis.
Clin Cardiol. 2012 Dec;35(12):E29-34. doi: 10.1002/clc.22072. Epub 2012 Oct 25.
9
Risk factors for progression of calcific aortic stenosis and potential therapeutic targets.
Int J Angiol. 2008 Summer;17(2):63-70. doi: 10.1055/s-0031-1278283.
10
Role of angiogenetic factors in cardiac valve homeostasis and disease.
J Cardiovasc Transl Res. 2011 Dec;4(6):727-40. doi: 10.1007/s12265-011-9317-8. Epub 2011 Aug 25.
本文引用的文献
1
Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis.
Circulation. 2004 Sep 7;110(10):1291-5. doi: 10.1161/01.CIR.0000140723.15274.53. Epub 2004 Aug 30.
2
Hemodynamic effects of the angiotensin-converting enzyme inhibitor, ramipril, in patients with mild to moderate aortic stenosis and preserved left ventricular function.
J Investig Med. 2004 Apr;52(3):185-91. doi: 10.1136/jim-52-03-33.
3
Isoprenoid metabolism and the pleiotropic effects of statins.
Curr Atheroscler Rep. 2003 Sep;5(5):372-8. doi: 10.1007/s11883-003-0008-z.
4
Human aortic valve calcification is associated with an osteoblast phenotype.
Circulation. 2003 May 6;107(17):2181-4. doi: 10.1161/01.CIR.0000070591.21548.69. Epub 2003 Apr 28.
5
Experimental aortic valve stenosis in rabbits.
J Am Coll Cardiol. 2003 Apr 2;41(7):1211-7. doi: 10.1016/s0735-1097(03)00090-1.
6
Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community.
J Am Coll Cardiol. 2002 Nov 20;40(10):1723-30. doi: 10.1016/s0735-1097(02)02496-8.
7
Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma.
Circulation. 2002 Oct 22;106(17):2224-30. doi: 10.1161/01.cir.0000035655.45453.d2.
8
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in atherosclerosis.
Curr Atheroscler Rep. 2002 Sep;4(5):363-72. doi: 10.1007/s11883-002-0074-7.
9
Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve.
Circulation. 2002 Jun 4;105(22):2660-5. doi: 10.1161/01.cir.0000017435.87463.72.
10
HMG CoA reductase inhibitor (statin) and aortic valve calcium.
Lancet. 2002 Mar 30;359(9312):1125-6. doi: 10.1016/S0140-6736(02)08161-8.
Zotero 插件